GCF2: expression and molecular analysis of repression

被引:35
作者
Rikiyama, T
Curtis, J
Oikawa, M
Zimonjic, DB
Popescu, N
Murphy, BA
Wilson, MA
Johnson, AC
机构
[1] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION | 2003年 / 1629卷 / 1-3期
关键词
epidermal growth factor receptor; transcription; repression; promoter; lymphoma;
D O I
10.1016/S0167-4781(03)00156-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
GC-binding factor 2 (GCF2) is a transcriptional repressor that decreases activity of the epidermal growth factor receptor (EGFR) and other genes. We have mapped the gene for GCF2 by fluorescence in situ hybridization (FISH) to chromosome 2q37. Sequence analysis of the GCF2 gene and cDNA showed that the gene consists of eight exons and introns and spans 73 kbp of DNA. Northern blot analysis showed that GCF2 mRNA was differentially expressed in many human tissues and cell lines. GCF2 mRNA was expressed as a 4.2 kb mRNA in most human tissues with the highest expression level in peripheral blood leukocytes and lowest expression in brain and testis. Additional transcripts of 6.6, 2.9 and 2.4 kb were found in some tissues but the only transcript detected in cancer cell lines was 4.2 kb with high levels found in seven Burkitts' lymphoma cell lines. Western blot analysis showed that GCF2 protein is present at high levels in Burkitts' lymphoma and several other cancer cell lines. GCF2 was found in both nuclear and cytoplasmic compartments in cells. Deletion mutants of GCF2 revealed that amino acids 429-528 are required for both DNA binding and repression of the EGFR promoter. Furthermore, GCF2 was able to substantially decrease activator protein 2 (AP2) enhancement of the EGFR promoter. Thus, GCF2 is a transcriptional repressor overexpressed in cancer cell lines with a role in regulating expression of the EGFR. Published by Elsevier B.V.
引用
收藏
页码:15 / 25
页数:11
相关论文
共 44 条
[31]   HUMAN-TUMOR CELL-LINES WITH EGF RECEPTOR GENE AMPLIFICATION IN THE ABSENCE OF ABERRANT SIZED MESSENGER-RNAS [J].
KING, CR ;
KRAUS, MH ;
WILLIAMS, LT ;
MERLINO, GT ;
PASTAN, IH ;
AARONSON, SA .
NUCLEIC ACIDS RESEARCH, 1985, 13 (23) :8477-8486
[32]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[33]   TARGETING THE EGF RECEPTOR IN BREAST-CANCER-TREATMENT [J].
LEMAISTRE, CF ;
MENEGHETTI, C ;
HOWES, L ;
OSBORNE, CK .
BREAST CANCER RESEARCH AND TREATMENT, 1994, 32 (01) :97-103
[34]   THE MORBID ANATOMY OF THE HUMAN GENOME - CHROMOSOMAL LOCATION OF MUTATIONS CAUSING DISEASE [J].
MCKUSICK, VA ;
AMBERGER, JS .
JOURNAL OF MEDICAL GENETICS, 1993, 30 (01) :1-26
[35]  
MITELMAN F, 1995, HUMAN GENE MAPPING, P1332
[36]   EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN BREAST-CANCER - ASSOCIATION WITH RESPONSE TO ENDOCRINE THERAPY [J].
NICHOLSON, RI ;
MCCLELLAND, RA ;
GEE, JMW ;
MANNING, DL ;
CANNON, P ;
ROBERTSON, JFR ;
ELLIS, IO ;
BLAMEY, RW .
BREAST CANCER RESEARCH AND TREATMENT, 1994, 29 (01) :117-125
[37]   p53 homologue p63 represses epidermal growth factor receptor expression [J].
Nishi, H ;
Senoo, M ;
Nishi, KH ;
Murphy, B ;
Rikiyama, T ;
Matsumura, Y ;
Habu, S ;
Johnson, AC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (45) :41717-41724
[38]  
Nishi H, 2002, CANCER RES, V62, P827
[39]   Genetic alterations in cancer as a result of breakage at fragile sites [J].
Popescu, NC .
CANCER LETTERS, 2003, 192 (01) :1-17
[40]   Molecular cloning and characterization of a transcription regulator with homology to GC-binding factor [J].
Reed, AL ;
Yamazaki, H ;
Kaufman, JD ;
Rubinstein, Y ;
Murphy, B ;
Johnson, AC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (34) :21594-21602